Regis Corp Files Q2 2025 10-Q
Ticker: RGS · Form: 10-Q · Filed: Feb 12, 2025 · CIK: 716643
| Field | Detail |
|---|---|
| Company | Regis Corp (RGS) |
| Form Type | 10-Q |
| Filed Date | Feb 12, 2025 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.05 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
**Regis Corp Q2 2025 10-Q filed. Shows franchisee revenue streams.**
AI Summary
Regis Corporation filed a 10-Q for the period ending December 31, 2024. The filing covers the second quarter of their fiscal year. Key financial data points and business segments are detailed within the report, including information on royalties, fees, and product sales from franchisees.
Why It Matters
This filing provides investors with an update on Regis Corporation's financial performance and operational status for the second quarter of fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing financial updates and does not indicate any immediate or significant risks.
Key Numbers
- 2024-12-31 — Period End Date (The end date for the reporting period of this 10-Q filing.)
- 2024-07-01 — Period Start Date (The start date for the reporting period of this 10-Q filing.)
Key Players & Entities
- REGIS CORP (company) — Filer of the 10-Q
- 20241231 (date) — Period of report
- 0000716643 (company) — Central Index Key for REGIS CORP
- 9529477777 (dollar_amount) — Business phone number
FAQ
What were Regis Corporation's royalty revenues for the three months ended December 31, 2024?
Royalty revenues for the three months ended December 31, 2024, were $0.05.
What were Regis Corporation's royalty revenues for the six months ended December 31, 2024?
Royalty revenues for the six months ended December 31, 2024, were not explicitly stated in the provided snippet, but the data for the period is available.
What were Regis Corporation's fees revenues for the three months ended December 31, 2024?
Fees revenues for the three months ended December 31, 2024, are available in the filing.
What were Regis Corporation's franchisee product sales for the three months ended December 31, 2024?
Franchisee product sales for the three months ended December 31, 2024, are available in the filing.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on February 12, 2025.
Filing Stats: 4,633 words · 19 min read · ~15 pages · Grade level 15.2 · Accepted 2025-02-12 06:02:22
Key Financial Figures
- $0.05 — ange on which registered Common Stock, $0.05 par value RGS The Nasdaq Global Market
Filing Documents
- rgs-20241231.htm (10-Q) — 1143KB
- rgs-20241231xex311.htm (EX-31.1) — 10KB
- rgs-20241231xex312.htm (EX-31.2) — 10KB
- rgs-20241231xex32.htm (EX-32) — 6KB
- 0000716643-25-000010.txt ( ) — 6881KB
- rgs-20241231.xsd (EX-101.SCH) — 51KB
- rgs-20241231_cal.xml (EX-101.CAL) — 94KB
- rgs-20241231_def.xml (EX-101.DEF) — 247KB
- rgs-20241231_lab.xml (EX-101.LAB) — 592KB
- rgs-20241231_pre.xml (EX-101.PRE) — 426KB
- rgs-20241231_htm.xml (XML) — 987KB
Financial Statements (Unaudited)
Financial Statements (Unaudited): Condensed Consolidated Balance Sheets as of December 31, 2024, and June 30, 2024 3 Condensed Consolidated Statements of Operations for the Three and Six Months Ended December 31, 2024, and 2023 4 Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended December 31, 2024, and 2023 5 Condensed Consolidated Statements of Shareholders' Equity (Deficit) for the Three and Six Months Ended December 31, 2024, and 2023 6 Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 31, 2024, and 2023 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 36 Item 4.
Controls and Procedures
Controls and Procedures 36 Part II. Other Information 37 Item 1.
Legal Proceedings
Legal Proceedings 37 Item 1A.
Risk Factors
Risk Factors 37 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39 Item 5. Other Information 39 Item 6. Exhibits 40
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION
Financial Statements (Unaudited)
Item 1. Financial Statements (Unaudited) REGIS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) As of December 31, 2024, and June 30, 2024 (Dollars in thousands, except per share data) December 31, 2024 June 30, 2024 ASSETS Current assets: Cash and cash equivalents (Note 7) $ 10,198 $ 10,066 Receivables, net 8,313 9,434 Other current assets 24,921 22,550 Total current assets 43,432 42,050 Property and equipment, net 10,699 3,664 Goodwill (Note 1) 188,975 173,146 Other intangibles, net 2,301 2,427 Right of use asset (Note 8) 266,513 287,912 Other assets 18,191 21,297 Total assets $ 530,111 $ 530,496 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 16,451 $ 12,747 Accrued expenses 20,097 21,644 Short-term lease liability (Note 8) 70,971 69,127 Total current liabilities 107,519 103,518 Long-term debt, net (Note 9) 111,532 99,545 Long-term lease liability (Note 8) 206,872 230,607 Other non-current liabilities 37,470 40,039 Total liabilities 463,393 473,709 Commitments and contingencies (Note 6) Shareholders' equity: Common stock, $ 0.05 par value; issued and outstanding, 2,435,979 and 2,279,948 common shares at December 31, 2024, and June 30, 2024, respectively 122 114 Additional paid-in capital 73,243 69,660 Accumulated other comprehensive income 8,132 8,584 Accumulated deficit ( 14,779 ) ( 21,571 ) Total shareholders' equity 66,718 56,787 Total liabilities and shareholders' equity $ 530,111 $ 530,496 _______________________________________________________________________________ The accompanying notes are an integral part of the unaudited Condensed Consolidated Financial Statements. 3 REGIS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the Three and Six Months Ended December 31, 2024, and 2023 (Dollars and shares in thousands, except per share amounts) Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 R